Firefly NeuroscienceAIFF +4.76%9 Quick Ratio is 1.78 as of Mar. 2026, which is 84% above its 10-year median of 0.97. GuruFocus rates AIFF with a GF Score™ of 9/100. The stock has 4 warning signs investors should review. Among 2,865 Software companies, Firefly Neuroscience ranks better than 52.29% on this metric.
Firefly Neuroscience has a quick ratio of 1.78. It generally indicates good short-term financial strength.
The historical rank and industry rank for Firefly Neuroscience's Quick Ratio or its related term are showing as below:
AIFF'
s Quick Ratio Range Over the Past 10 Years
Min: 0.04 Med: 0.97 Max: 2.65
Current: 1.78
During the past 5 years, Firefly Neuroscience's highest Quick Ratio was 2.65. The lowest was 0.04. And the median was 0.97.
AIFF's Quick Ratio is ranked better than 52.29% of 2865
companies
in the Software industry
Industry Median: 1.7
vs AIFF: 1.78
Firefly Neuroscience (NAS:AIFF) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Firefly Neuroscience Quick Ratio Related Terms
Firefly Neuroscience Quick Ratio Historical Data
* Premium members only.
The historical data trend for Firefly Neuroscience's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Application subindustry, Firefly Neuroscience's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Firefly Neuroscience Quick Ratio vs Software Industry
For the Software industry and Technology sector, Firefly Neuroscience's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Firefly Neuroscience's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Firefly Neuroscience's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Firefly Neuroscience (AIFF) has a Quick Ratio of 1.78 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Firefly Neuroscience and its competitors. This is 84% above median its historical median of 0.97. Over the past decade, Firefly Neuroscience's Quick Ratio has ranged from 0.04 to 2.65. According to the industry distribution chart, Firefly Neuroscience ranks #1367 out of 2865 companies in the Software industry, placing it in the top 47.7%.
Is Firefly Neuroscience's Quick Ratio too high?
Firefly Neuroscience's current Quick Ratio of 1.78 is 84% above median its 10-year median of 0.97. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 2.65. The Software industry median Quick Ratio is 1.70. Firefly Neuroscience's value of 1.78 is 4.7% above this industry median. Based on the distribution chart, Firefly Neuroscience ranks #1367 out of 2865 companies in the Software industry, which is above the industry midpoint. Overall, Firefly Neuroscience has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Firefly Neuroscience's Quick Ratio compare to LPSN and AVAI?
According to the Software industry distribution chart, Firefly Neuroscience ranks #1367 out of 2865 companies for Quick Ratio. This puts Firefly Neuroscience in the upper half of its industry. The industry median Quick Ratio is 1.70. Firefly Neuroscience's value of 1.78 is 4.7% above this benchmark. Historically, Firefly Neuroscience's own Quick Ratio has ranged from 0.04 to 2.65 over the past decade. While the company's 10-year median is 0.97 vs. the industry median of 1.70, Firefly Neuroscience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Software company?
The median Quick Ratio among Software companies is 1.70, based on 2,865 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Firefly Neuroscience's current Quick Ratio of 1.78 is 4.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Firefly Neuroscience and its competitors. For the Software industry, the median Quick Ratio is 1.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Firefly Neuroscience's current Quick Ratio is 1.78, which is 84% above median its own 10-year median of 0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Firefly Neuroscience stock overvalued right now?
Firefly Neuroscience (AIFF) has a current Quick Ratio of 1.78. The current Quick Ratio is 1.78, which is 84% above median its 10-year median of 0.97 and 4.7% above the Software industry median of 1.70. Firefly Neuroscience's overall GF Score™ is 9/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Firefly Neuroscience (AIFF), the current Quick Ratio is 1.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.
9GF Score
Get the complete analysis for AIFF
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIFF has been successfully added to your 
